RA0618

antibody from Oursmab

Targeting: PTK7 CCK4

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0618

Provider

Oursmab

Product name

Cofetuzumab (Biosimilar Reference Antibody) (PTK7)

Antibody type

Monoclonal

Description

Cofetuzumab (also known as PF-06647020) is an investigational antibody-drug conjugate (ADC) developed for the treatment of solid tumors. It is designed to deliver a potent cytotoxic agent specifically to cancer cells that overexpress a particular tumor-associated antigen, thereby aiming to maximize anti-tumor efficacy while limiting systemic toxicity. Clinical trials have evaluated its safety and preliminary efficacy in patients with advanced cancers, including platinum-resistant ovarian cancer and triple-negative breast cancer.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.